RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Transcode Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.70+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $1.63M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Transcode Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 2, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2025 | Oct 8, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Oct 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Sep 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 29, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 2, 2025 | May 2, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2025 | Apr 21, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 21, 2025 | Apr 11, 2025 | SEC EDGAR |